Darzi moves to speed NICE processes welcomed
Industry and patient groups have broadly welcomed the proposals to speed up and broaden the availability of innovative medicines which are outlined by Professor Lord Ara Darzi in his report on the National Health Service (NHS), published this week.
Oxford BioMedica rejects lawsuit brought by Bavarian Nordic
Oxford BioMedica has been hit by a patent infringement lawsuit in the USA brought by rival vaccine specialists Bavarian Nordic over three patents relating to the Modified Vaccinia Ankara (MVA) technology
Shire gets hold of Jerini's Firazyr in 328 million euro takeover
Shire is splashing out 328 million euros to buy Jerini, giving it access to the German biotechnology company’s icatibant for the treatment of hereditary angioedema
|
 |
Minister accuses GPs of “gentlemen’s agreements” to keep practice lists closed
On the eve of the delayed launch of the Darzi Review primary care strategy, Health Minister Ben Bradshaw has hit out at GPs for preventing patient choice by preventing practice lists being open to new patients.
MHRA consults industry on EU license harmonisation plans
The Medicines and Healthcare product Regulatory Agency (MHRA) has launched a public consultation on European Commission proposals to harmonise the handling of variations to national medicine licenses.
UK concerns about 'health tourism' costs after EC directive
The UK Government has responded with caution to draft proposals from the European Commission which would guarantee that the cost of treatment in any EU member state is reimbursed by the patient's own national health scheme
|